Publications by authors named "YunWei Han"

Claim this Profile
C
Case Report: Rapid resolution of malignant acanthosis nigricans following chemotherapy for cervical cancer.
Min Hu, Xiangrui Chen, Xiaobo Tong, Chengluo Hao, Yunwei Han

Front Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WWP2-induced inhibition of hepatocellular carcinoma cellular senescence via the ubiquitination and degradation of p21.
Xiaojing Chen, Jihong Wang, Zihan Yan, Xinrui Du, Zhiyao Zhang, Jing Zhang, Yunwei Han

Cell Death Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence-based personalized treatment strategies for unresectable hepatocellular carcinoma: integrating HSP90α for prognosis and survival prediction.
Ke Su, Xin Liu, Xuelian Wang, Yunwei Han, Huiyan Luo, Han Li, Jianwen Zhang, Yuhang Zhou, Guixu Zhang

NPJ Digit Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ANG secretion predisposes endothelial cells toward angiogenesis in FIN56-induced ferroptotic hepatocellular carcinoma via the BMP6/ID1 signaling pathway.
Xin Liu, Gang Long, Qingwen Wang, Jihong Wang, Xiaojing Chen, Yuhang Zhou, Han Li, Zhiyao Zhang, Yunwei Han

Free Radic Biol Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A gelatin sponge-hemocoagulase sealant for preventing tumor biopsy complications: a dual mechanical and pharmacological barrier.
Xiangrui Chen, Min Hu, Lunfei Du, Chengluo Hao, Hui Yang, Yunwei Han

Front Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Three-year follow-up of TACE for recurrent undifferentiated pleomorphic sarcoma: sustained local control and no systemic progression.
Xiangrui Chen, Min Hu, Chengluo Hao, Limei Ma, Yunwei Han

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palbociclib stimulates CD8 + T cell response in triple-negative breast cancer via regulating phosphoglycerate dehydrogenase.
Yuanyuan Sun, Yaqing Li, Yunwei Han, Chenying Liu, Yuanming Song

Anticancer Drugs· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinoma.
Ke Xu, Tao Gu, Ke Su, Xin Liu, Bingsheng He, Hanlin Liu, Han Li, Yunwei Han

Discov Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The joint role of systemic immune-inflammation index and geriatric nutritional risk index in cancer survivors and their impact on all-cause mortality.
Xiangrui Chen, Min Hu, Chengluo Hao, Jun Li, Yunwei Han

Front Nutr· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancer.
Zefei Jiang, Quchang Ouyang, Tao Sun, Qingyuan Zhang, Yuee Teng, Lili Zhang, Qingshan Li, Anqin Zhang, Yongqiang Zhang, Helong Zhang, Yunwei Han

Future Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of the combination of envafolimab and lenvatinib in unresectable hepatocellular carcinoma: a single-arm, multicentre, exploratory phase II clinical study.
Yi Jiang, Ke Su, Han Li, Chenjie Wang, Zhenying Wu, Zhiyao Zhang, Yunwei Han

Invest New Drugs· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lasso-Cox interpretable model of AFP-negative hepatocellular carcinoma.
Han Li, Chengyuan Zhou, Chenjie Wang, Bo Li, Yanqiong Song, Yan Zhang, Jianwen Zhang, Yunwei Han

Clin Transl Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nomogram model based on γ-glutamyl transferase to albumin ratio predicts survival in hepatocellular carcinoma patients with transarterial chemoembolization treatment.
Zhen-Ying Wu, Han Li, Jia-Li Chen, Ke Su, Mei-Ling Weng, Yun-Wei Han

World J Gastrointest Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the Curcumin Analog CA7 Liposome and Its Evaluation for Efficacy Against Cervical Cancer in vitro and in vivo.
Linjin Xiong, Yumeng Wei, Hui Si, Zheng Li, Jie Wen, Yunwei Han

Int J Nanomedicine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trial.
Jian Zhang, Minghao Li, Kaixian Zhang, Anping Zheng, Guang Li, Xianwen Zhang, Yunwei Han

Cancer Commun (Lond)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction of an interpretable model for predicting survival outcomes in patients with middle to advanced hepatocellular carcinoma (≥5 cm) using lasso-cox regression.
Han Li, Bo Yang, Chenjie Wang, Bo Li, Lei Han, Jianwen Zhang, Yunwei Han

Front Pharmacol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-30c suppresses the proliferation, metastasis and polarity reversal of tumor cell clusters by targeting MTDH in invasive micropapillary carcinoma of the breast.
Yunwei Han, Weidong Li, Renyong Zhi, Gui Ma, Ang Gao

Heliyon· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple-negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding.
Xupeng Hou, Xueyang Li, Yunwei Han, Hua Xu, Yongjie Xie

Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of circulating tumor cells combined with neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma.
Jia-Li Chen, Lu Guo, Zhen-Ying Wu, Kun He, Han Li, Yun-Wei Han

World J Gastrointest Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial.
Zefei Jiang, Quchang Ouyang, Tao Sun, Qingyuan Zhang, Yuee Teng, Lili Zhang, Qingshan Li, Anqin Zhang, Yongqiang Zhang, Helong Zhang, Yunwei Han

Nat Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
Benjian Gao, Fengyi Yang, Dongning Zheng, Shuai Hu, Jie Liu, Yunwei Han

J Hepatocell Carcinoma· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study.
Yi Jiang, Lu Guo, Lei Han, Han Li, Changlun Li, Yushan Yan, Yunwei Han

J Cancer Res Clin Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of external beam radiation therapy versus transcatheter arterial chemoembolization for non-diffuse hepatocellular carcinoma (≥ 5 cm): a multicenter experience over a ten-year period.
Ke Su, Fei Wang, Xueting Li, Hao Chi, Jianwen Zhang, Han Li, Yunwei Han

Front Immunol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transhepatectomy combined with arterial chemoembolization and transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a clinical prognostic analysis.
Xin Liu, Haodong Li, Fei Wang, Ke Su, Bingsheng He, Yunwei Han

BMC Gastroenterol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of anlotinib plus XELOX regimen as first-line therapy for mCRC: a single-arm, multicenter, phase II study (ALTER-C-001).
Bo Song, Hai Hu, Li Zhang, Su-Juan Ye, Yong-Dong Jin, Chang-Ling Shang, Jun Zhang, Ke Zhang, Yun-Wei Han

Front Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis